Pre-S Deletion and Complex Mutations of Hepatitis B Virus Related to Advanced Liver Disease in HBeAg-Negative Patients

Gastroenterology

Volumn 133, Issue 5, 2007, Pages 1466-1474

  Chen, Chien Hung ^a   Hung, Chao Hung ^a   Lee, Chuan Mo ^a,b   Hu, Tsung Hui ^a   Wang, Jing Houng ^a   Wang, Jyh Chwan ^a   Lu, Sheng Nan ^a   Changchien, Chi Sin ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; HEPATITIS B(E) ANTIGEN; MOLECULAR MARKER; VIRUS DNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE DELETION; GENE INTERACTION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MUTANT; MUTATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROMOTER REGION; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; VIRUS CARRIER;

ADULT; BILIRUBIN; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; GENE DELETION; GENOTYPE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MUTATION; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; REGRESSION ANALYSIS; VIRAL CORE PROTEINS;

EID: 35649014367     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.09.002     Document Type: Article

References (44)

1. Chu C.M., Hung S.J., Lin J., et al. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels. Am J Med 116 (2004) 829-834
2. Hsu Y.S., Chien R.N., Yeh C.T., et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 35 (2002) 1522-1527
3. Hadziyannis S.J., and Vassilopoulos D. Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34 (2001) 617-624
4. Brunetto M.R., Giarin M., Oliveri F., et al. Wild type and e antigen-minus hepatitis B virus in course of chronic hepatitis. Proc Natl Acad Sci U S A 88 (1991) 4186-4190
5. Naoumov N.V., Schneider R., Grotzinger T., et al. Precore mutant hepatitis B virus infection and liver disease. Gastroenterology 102 (1992) 538-543
6. Carman W.F., Jacyna M.R., Hadziyannis S., et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 2 (1989) 588-591
7. Akahane Y., Yamanaka T., Suzuki H., et al. Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum. Disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region. Gastroenterology 99 (1990) 1113-1119
8. Hamasaki K., Nakata K., Nagayama Y., et al. Changes in the prevalence of HBeAg-negative mutants hepatitis B virus during the course of chronic hepatitis B. Hepatology 20 (1994) 8-14
9. Okamoto H., Tsuda F., Akahane Y., et al. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 68 (1994) 8102-8110
10. Kurosaki M., Enomoto N., Asahina Y., et al. Mutations in the core promoter region of hepatitis B virus in patients with chronic hepatitis B. J Med Virol 49 (1996) 115-123
11. Buckwold V.E., Xu Z., Chen M., et al. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol 70 (1996) 5845-5851
12. Gu{double acute}nther S., Piwon N., and Will H. Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653)→T,A(1762) →T and G (1764) → A mutations in the core promoter. J Gen Virol 79 (1998) 375-380
13. Chen C.H., Lee C.M., Lu S.N., et al. Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan. J Clin Microbiol 43 (2005) 6000-6006
14. Kao J.H., Chen P.J., Lai M.Y., et al. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 124 (2003) 327-334
15. Lindh M., Hannoun C., Dhillon A.P., et al. Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J Infect Dis 179 (1999) 775-782
16. Lee C.M., Chen C.H., Lu S.N., et al. Prevalence of clinical implications of hepatitis B virus genotypes in southern Taiwan. Scand J Gastroenterol 1 (2003) 95-101
17. Kao J.H., Chen P.J., Lai M.Y., et al. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 118 (2000) 554-559
18. Yuen M.F., Sablon E., Yuan H.J., et al. Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma. Hepatology 37 (2003) 562-567
19. Sumi H., Yokosuka O., Seki N., et al. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 37 (2003) 19-26
20. Lin C.L., Liao L.Y., Wang C.S., et al. Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B. Liver Int 25 (2005) 564-570
21. Chun Y.K., Kim J.Y., Woo H.J., et al. No significant correlation exists between core promoter mutations, viral replication, and liver damage in chronic hepatitis B infection. Hepatology 32 (2000) 1154-1162
22. Chisari F.V. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13 (1995) 29-60
23. Ganem D. Assembly of hepadnaviral virions and subparticles. Curr Top Microbiol Immunol 168 (1991) 61-83
24. Sobotta D., Sominskaya I., Jansons J., et al. Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype. J Gen Virol 81 (2000) 369-378
25. Fan Y.F., Lu C.C., Chen W.C., et al. Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection. Hepatology 33 (2001) 277-286
26. Pollicino T., Zanetti A.R., Cacciola I., et al. Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. Hepatology 26 (1997) 495-499
27. Sugauchi F., Ohno T., Orito E., et al. Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease. J Med Virol 70 (2003) 537-544
28. Chen B.F., Liu C.J., Jow G.M., et al. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130 (2006) 1153-1168
29. Lin D.Y., Sheen I.S., Chiu C.T., et al. Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: a longitudinal study. J Clin Ultrasound 21 (1993) 303-308
30. Hung C.H., Lu S.N., Wang J.H., et al. Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis. J Gastroenterol 38 (2003) 153-157
31. Chen C.H., Lee C.M., Lu S.N., et al. Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapy. J Hepatol 44 (2006) 76-82
32. Mizokami M., Nakano T., Orito E., et al. Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns. FEBS Lett 450 (1999) 66-71
33. Baumert T.F., Rogers S.A., Hasegawa K., et al. Two core promoter mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest 98 (1996) 2268-2276
34. Baumert T.F., Yang C., Schurmann P., et al. Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes. Hepatology 41 (2005) 247-256
35. Wang H.C., Wu H.C., Chen C.F., et al. Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that induce endoplasmic reticulum stress. Am J Pathol 163 (2003) 2441-2449
36. Chisari F.V., Klopchin K., Moriyama T., et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59 (1989) 1145-1156
37. Fan Y.F., Lu C.C., Chang Y.C., et al. Identification of a pre-S2 mutant in hepatocytes expressing a novel margin pattern of surface antigen in advanced disease of chronic hepatitis B virus infection. J Gastroenterol Hepatol 15 (2000) 519-528
38. Hsieh Y.H., Su I.J., Wang H.C., et al. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25 (2004) 2023-2032
39. Preikschat P., Gunther S., Reinhold S., et al. Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients. Hepatology 35 (2002) 466-477
40. Marschenz S., Endres A.S., Brinckmann A., et al. Function analysis of complex hepatitis B virus variants associated with development of liver cirrhosis. Gastroenterology 131 (2006) 765-780
41. Iloeje U.H., Yang H.I., Lu J., et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 130 (2006) 678-686
42. Chen C.J., Yang H.I., Su J., et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295 (2006) 65-73
43. Regev A., Berho M., Jeffers L.J., et al. Sampling error and intraobserver variation on liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97 (2002) 2614-2618
44. Nishiura T., Watanabe H., Ito M., et al. Ultrasound evaluation of the fibrosis stage in chronic liver disease by the simultaneous use of low and high frequency probes. Br J Radiol 78 (2005) 189-197